论文部分内容阅读
目的:探讨奥扎格雷钠、尤瑞克林用于治疗急性脑梗死的临床价值分析。方法:将2015年11月-2016年11月在我院神经内科治疗的90例急性脑梗死患者随机分为两组,对照组单用奥扎格雷钠治疗,观察组采用奥扎格雷钠联合尤瑞克林治疗,比较两组患者的治疗效果、神经功能。结果:观察组治疗有效率为93.33%,显著高于对照组的75.56%,两组间差异显著(P<0.05);观察组治疗14d、28dNIHSS评分明显低于对照组,差异有统计学意义(P<0.05)。结论:奥扎格雷钠、尤瑞克林用于治疗急性脑梗死的临床效果显著,改善缺血区血液循环,促进神经功能的修复,具有积极的临床意义。
Objective: To investigate the clinical value of ozagrel sodium and erilecin in the treatment of acute cerebral infarction. Methods: Ninety patients with acute cerebral infarction who were treated in Department of Neurology from November 2015 to November 2016 were randomly divided into two groups. The control group was treated with ozagrel sodium alone. The observation group was treated with sodium ozagrel Racinth treatment, the treatment effect of two groups of patients, neurological function. Results: The effective rate of the observation group was 93.33%, significantly higher than that of the control group (75.56%), the difference between the two groups was significant (P <0.05); the NIHHSS score of the observation group was significantly lower than that of the control group on the 14th and 28th days P <0.05). Conclusion: Ozagrel sodium and erilecin have significant clinical effects for the treatment of acute cerebral infarction. It has positive clinical significance in improving blood circulation and promoting the repair of nerve function in ischemic area.